Sanjay K. Agarwal

ORCID: 0000-0002-8046-9807 · 68 papers in corpus
observational 2026
bioRxiv : the preprint server for biology ·doi:10.64898/2026.01.05.696004

Endometriosis affects approximately 10% of reproductive-age women worldwide and is associated with substantial pain and mental health burden, yet its neurobiological correlates remain poorly characterized. Neuroimaging studies of endometrio…

observational 2026
·doi:10.2147/ijwh.s594255

Purpose: To characterize the experiences of individuals taking hormonal therapies to manage their symptoms of endometriosis (EM) or uterine fibroids (UF). Patients and Methods: This prospective, 16-week observational study enrolled US parti…

observational 2026
International journal of women's health ·doi:10.2147/IJWH.S594255

PURPOSE: To characterize the experiences of individuals taking hormonal therapies to manage their symptoms of endometriosis (EM) or uterine fibroids (UF). PATIENTS AND METHODS: This prospective, 16-week observational study enrolled US part…

observational 2025
International journal of women's health ·doi:10.2147/ijwh.s523846

BACKGROUND: Limited evidence is available regarding preferences of women with uterine fibroids (UF) and treating healthcare providers (HCPs) regarding treatment attributes; this evidence could contribute to patient-centered shared decision-…

other 2024
Advances in therapy ·doi:10.1007/s12325-024-02970-2

Endometriosis is a common disease, affecting approximately 5-10% of reproductively aged women. Symptoms, such as painful periods, negatively impact an individual's quality of life; however, these symptoms are often normalized, leading to de…

nonrandomized-trial 2024
International journal of women's health ·doi:10.2147/IJWH.S467041

PURPOSE: To evaluate the impact of an interleukin-1 (IL-1) antagonist anakinra (Kineret®) on endometriosis-related quality of life (QoL), pain, and inflammatory biomarkers. METHODS: This was a single-site, randomized, double-blinded, place…

observational 2024
AJOG global reports ·doi:10.1016/j.xagr.2024.100412

BACKGROUND: Historically, the clinical characteristics and treatment pathways for patients with uterine fibroids and heavy menstrual bleeding have differed between White and Black women. OBJECTIVE: To provide a contemporary comparison of p…

review 2023
Reproduction & fertility ·doi:10.1530/raf-22-0091

Endometriosis is a chronic disease associated with debilitating pain that affects many people assigned female at birth, from menarche through menopause, not just causing pain and infertility, but also negatively impacting quality of life, p…

observational 2023
International journal of women's health ·doi:10.2147/ijwh.s420612

INTRODUCTION: This retrospective database claims analysis describes the clinical characteristics and treatment patterns of commercially insured United States women with uterine fibroids (UF) and heavy menstrual bleeding (HMB). METHODS: Wom…

qualitative 2023
International journal of women's health ·doi:10.2147/ijwh.s409733

OBJECTIVE: This interview study sought to capture patients' experiences and perceptions of endometriosis symptoms and their impacts on daily life, as described by women in their own words. Using open-ended questions and a concept-elicitatio…

observational 2023
International journal of women's health ·doi:10.2147/ijwh.s424554

PURPOSE: The diagnosis of endometriosis often takes several years, delaying appropriate care while patients suffer from pelvic pain, dysmenorrhea, and dyspareunia. Understanding whether residents in obstetrics and gynecology (OB/GYN) are be…

2022
·doi:10.1007/978-3-030-97236-3_43
review 2021
Biology of reproduction ·doi:10.1093/biolre/ioab134

Endometriosis is a common gynecological condition characterized by estrogen dependence, chronic pelvic pain, infertility, and diagnostic delay of between 5.4 and 12 years. Despite extensive study, no biomarker, either alone or in combinatio…

observational 2021
Scientific reports ·doi:10.1038/s41598-021-98380-3

Endometriosis is a chronic, estrogen-dependent gynecological condition affecting approximately 10% of reproductive age women. The most widely accepted theory of its etiology includes retrograde menstruation. Recent reports suggest the uteru…

other 2021
Journal of pain research ·doi:10.2147/JPR.S284703

OBJECTIVE: In this post hoc analysis, we evaluated the impact of elagolix on dysmenorrhea and nonmenstrual pelvic pain across menstrual period (bleeding days) and nonmenstrual (nonbleeding) days. METHODS: Data from two randomized, 6-month,…

review 2021
International journal of general medicine ·doi:10.2147/IJGM.S261139

Endometriosis may exert a profound negative influence on the lives of individuals with the disorder, adversely affecting quality of life, participation in daily and social activities, physical and sexual functioning, relationships, educatio…

observational 2021
BMC women's health ·doi:10.1186/s12905-020-01139-7

BACKGROUND: Women with endometriosis are commonly treated by their sole provider. In this single-provider model of care, women frequently report long diagnostic delays, unresolved pelvic pain, multiple laparoscopic surgeries, sequential con…

2021
·doi:10.1016/j.fertnstert.2021.07.553
2021
·doi:10.1016/j.jmig.2021.09.431
rct 2020
The journal of sexual medicine ·doi:10.1016/j.jsxm.2020.08.002

BACKGROUND: Dyspareunia experienced by women diagnosed with endometriosis is associated with a decreased health-related quality of life (HRQoL). AIM: We evaluated the relationship of clinically meaningful improvements in dyspareunia with H…

review 2020
Therapeutic advances in reproductive health ·doi:10.1177/2633494120964517

While the most common symptom associated with endometriosis is pelvic pain, the systemic manifestations of the disease and the accompanying adverse psychological, emotional, social, familial, sexual, educational and workplace effects are in…

other 2020
Scientific reports ·doi:10.1038/s41598-020-77046-6

Circulating concentrations of brain-derived neurotrophic factor (BDNF) have been linked to cancer, neuropsychiatric, diabetes, and gynecological disorders. However, factors influencing plasma storage and subsequent BDNF quantification are i…

review 2020
·doi:10.5772/intechopen.91324

Endometriosis is a common estrogen dependent and inflammatory disease affecting approximately 176 million women worldwide. Currently, the time between onset of symptoms and a definitive diagnosis has been reported by several international s…

observational 2020
Journal of women's health (2002) ·doi:10.1089/jwh.2019.7879

Introduction: Endometriosis is a burdensome chronic condition for which conservative management is often recommended when indicated. Nonetheless, some women seek care for endometriosis in the emergency department (ED). We evaluated trends i…

other 2020
Expert review of pharmacoeconomics & outcomes research ·doi:10.1080/14737167.2021.1832468

INTRODUCTION: We evaluated elagolix and leuprolide from the patient's perspective for the treatment of endometriosis-related pain. AREA COVERED: Preference weights from a published discrete choice experiment were used to evaluate preferenc…